NIMBEX 2 mg/ml, solution for injection/for infusion 5 ampoules of 2.5 ml
Active ingredients: BÉSILATE DE CISATRACURIUM, CISATRACURIUM
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection or infusion5 ampoules of 2.5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NIMBEX 2 mg/ml, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 2,5 ml
- Marketing authorisation holder
- ASPEN PHARMA TRADING (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 19 Apr 1997
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68123109CIP75595340CIP133400955953401Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CISATRACURIUMsolution | 2 mg · 1 ml | FT |
| BÉSILATE DE CISATRACURIUMsolution | 2,68 mg · 1 ml | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BESILATE DE CISATRACURIUM équivalant à CISATRACURIUM 2 mg/ml - NIMBEX 2 mg/ml, solution injectable/pour perfusion